{"anticipatedPostingDate":"2028-07","denomUnitsSelected":"Participants","description":"EFS is defined as the dates of randomization until death due to any cause or failure to achieve CR by end of induction or relapse from CR. CR: meeting all the following for at least 4 weeks (that is no recurrence):1. No circulating blasts and less than (\\<) 5% blasts in the bone marrow (BM). 2. Normal maturation of all cellular components in the BM. 3. No extramedullary disease (central nervous system \\[CNS\\] involvement, lymphadenopathy, splenomegaly, skin/gum infiltration, testicular mass). 4. Absolute neutrophil count (ANC) greater than (\\>) 1000 per micro liter (/mcL) (or \\>1.0\\*10\\^9/L). 5. Platelets \\>100,000/mcL (or \\>100\\*10\\^9/L).Relapse from CR: reappearance of blasts in the blood or BM (\\>=5%) or in any extramedullary site after a CR.","reportingStatus":"NOT_POSTED","timeFrame":"Baseline up to approximately 3 to 6 years","title":"Event-free Survival (EFS)","type":"SECONDARY"}